Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
11.199 / 17.034
#89585

Re: Farmas USA

Me acaba de llegar, nuevas coverturas .

Healthcare ratings roundup - new coverage

Jun 10 2016, 07:19 ET | By:  Douglas W. House, SA News Editor 

 

Boston Scientific (NYSE: BSX) initiated with Buy rating and $26 (13% upside) price target by Guggenheim Securities.

Zimmer Biomet Holdings (NYSE: ZBH) initiated with Neutral rating and $140 (18% upside) price target by Guggenheim Securities.

Edwards Lifesciences (NYSE: EW) initiated with Neutral rating and $120 (18% upside) price target by Guggenheim Securities.

Oncobiologics (Pending: ONS) initiated with Buy rating and $15 (218% upside) price target by Cantor Fitzgerald.

Walgreens Boots Alliance (NASDAQ: WBA) reinstated with Buy rating and $95 (20% upside) price target by Bank of America.

Goldman Sachs initiates coverage of specialty pharma with a Neutral rating:  Buy: Jazz Pharma (NASDAQ: JAZZ) - $196 (26% upside) price target, Horizon Pharma (NASDAQ: HZNP) - $24 (30% upside) price target;  Neutral: Endo International (NASDAQ: ENDP) - $20 (11% upside) price target, Mallinckrodt (NYSE: MNK) - $73 (17% upside) price target, Momenta Pharmaceuticals (NASDAQ: MNTA) - $14 (19% upside) price target; Concordia Healthcare (NASDAQ: CXRX) - $32 (31% upside) price target;  Sell: Impax Laboratories (NASDAQ: IPXL) - $33 (2% downside risk) price target.

Biocept (NASDAQ: BIOC) initiated with Buy rating and $1.20 (71% upside) price target by Roth Capital.

Seres Therapeutics (NASDAQ: MCRB) initiated with Outperform rating and $40 (22% upside) price target by Cowen & Company.

Omeros (NASDAQ: OMER) initiated with Buy rating and $21 (94% upside) price target by Cantor Fitzgerald.

Glaukos (NYSE: GKOS) initiated with Buy rating and $35 (30% upside) price target by Cantor Fitzgerald.

Shire plc (NASDAQ: SHPG) initiated with Overweight rating and GBX5,600 (34% upside) price target by Morgan Stanley.

#89586

Re: Farmas USA

ACHN,
No se framus, probablemente hoy se de la vuelta pero las news de EHA de esta mañana deberían por lo menos servir de gap up a apertura. veremos a ver...

#89588

Re: Farmas USA

ACHN
a ver! desde luego, el sector no acompaña nada hoy! he puesto orden de venta de apertura de un % pequeño de mis acciones, por si hubiera sorpresa en apertura, no vaya a ser que necesite cash para mas NVAX ;)

#89589

Re: Farmas USA

NVAX

Pues ahí dice que Stan mostró una diapositiva con la fase III completada y que partner en los próximos 3-6 meses; el quid de la cuestión es cuál.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#89592

Re: Farmas USA

Nvax
No la veo cómoda en rojo !vamos!